Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma
Conditions: Multiple Myeloma; Refractory Multiple Myeloma
Interventions: Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation; Procedure: allogeneic bone marrow transplantation; Drug: bortezomib; Drug: melphalan; Drug: anti-thymocyte globulin; Drug: sirolimus; Drug: tacrolimus; Radiation: total-body irradiation
Sponsor: Mayo Clinic
Withdrawn - verified February 2011
Interventions: Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation; Procedure: allogeneic bone marrow transplantation; Drug: bortezomib; Drug: melphalan; Drug: anti-thymocyte globulin; Drug: sirolimus; Drug: tacrolimus; Radiation: total-body irradiation
Sponsor: Mayo Clinic
Withdrawn - verified February 2011